middle.news
How Resonance Health’s $733K R&D Refund Fuels Medical Innovation
2:32pm on Monday 16th of March, 2026 AEDT
•
Healthcare
Read Story
How Resonance Health’s $733K R&D Refund Fuels Medical Innovation
2:32pm on Monday 16th of March, 2026 AEDT
Key Points
Received $732,851 net R&D tax incentive refund for FY2025
Refund reflects $832,959 R&D claim minus $100,108 income tax payable
Cash boost to be reflected in March 2026 quarterly report
Company specialises in AI-enhanced MRI diagnostic software
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE